BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 9283107)

  • 1. Comparison of fluorine-18 fluorodeoxyglucose positron emission tomography and technetium-99m methoxyisobutylisonitrile scintimammography in the detection of breast tumours.
    Palmedo H; Bender H; Grünwald F; Mallmann P; Zamora P; Krebs D; Biersack HJ
    Eur J Nucl Med; 1997 Sep; 24(9):1138-45. PubMed ID: 9283107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Technetium-99m-MIBI scintimammography by planar and SPECT imaging in the diagnosis of breast carcinoma and axillary lymph node involvement.
    Myslivecek M; Koranda P; Kamínek M; Husák V; Hartlová M; Dusková M; Cwiertka K
    Nucl Med Rev Cent East Eur; 2004; 7(2):151-5. PubMed ID: 15968602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of FDG-PET with MIBI-SPECT in the detection of breast cancer and axillary lymph node metastasis.
    Yutani K; Shiba E; Kusuoka H; Tatsumi M; Uehara T; Taguchi T; Takai SI; Nishimura T
    J Comput Assist Tomogr; 2000; 24(2):274-80. PubMed ID: 10752892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of whole-body 18F-FDG PET, 99mTc-MIBI SPET, and post-therapeutic 131I-Na scintigraphy in the detection of metastatic thyroid cancer.
    Iwata M; Kasagi K; Misaki T; Matsumoto K; Iida Y; Ishimori T; Nakamoto Y; Higashi T; Saga T; Konishi J
    Eur J Nucl Med Mol Imaging; 2004 Apr; 31(4):491-8. PubMed ID: 14666387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 99mTc-(V)DMSA scintimammography in the assessment of breast lesions: comparative study with 99mTc-MIBI.
    Papantoniou V; Christodoulidou J; Papadaki E; Valotassiou V; Stipsanelli A; Louvrou A; Lazaris D; Sotiropoulou M; Pampouras G; Keramopoulos A; Michalas S; Zerva C
    Eur J Nucl Med; 2001 Jul; 28(7):923-8. PubMed ID: 11504092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metastatic axillary lymph node technetium-99m-MIBI imaging in primary breast cancer.
    Taillefer R; Robidoux A; Turpin S; Lambert R; Cantin J; Léveillé J
    J Nucl Med; 1998 Mar; 39(3):459-64. PubMed ID: 9529292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective evaluation of fluorine-18-FDG PET in presurgical staging of the axilla in breast cancer.
    Crippa F; Agresti R; Seregni E; Greco M; Pascali C; Bogni A; Chiesa C; De Sanctis V; Delledonne V; Salvadori B; Leutner M; Bombardieri E
    J Nucl Med; 1998 Jan; 39(1):4-8. PubMed ID: 9443729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 11C-acetate PET imaging of lung cancer: comparison with 18F-FDG PET and 99mTc-MIBI SPET.
    Higashi K; Ueda Y; Matsunari I; Kodama Y; Ikeda R; Miura K; Taki S; Higuchi T; Tonami H; Yamamoto I
    Eur J Nucl Med Mol Imaging; 2004 Jan; 31(1):13-21. PubMed ID: 14574513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 18F-FDG PET and 99mTc-sestamibi scintimammography for monitoring breast cancer response to neoadjuvant chemotherapy: a comparative study.
    Tiling R; Linke R; Untch M; Richter A; Fieber S; Brinkbäumer K; Tatsch K; Hahn K
    Eur J Nucl Med; 2001 Jun; 28(6):711-20. PubMed ID: 11440031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tc-99m MIBI scintigraphy in patients with lung cancer. Comparison with CT and fluorine-18 FDG PET imaging.
    Wang H; Maurea S; Mainolfi C; Fiore F; Gravina A; Panico MR; Bazzicalupo L; Salvatore M
    Clin Nucl Med; 1997 Apr; 22(4):243-9. PubMed ID: 9099482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of planar scintimammography with 99mTc-MIBI in the detection of axillary lymph node metastases of breast carcinoma.
    Danielsson R; Boné B; Perbeck L; Aspelin P
    Acta Radiol; 1999 Sep; 40(5):491-5. PubMed ID: 10485237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using Tc-99m MIBI scintimammography to differentiate nodular lesions in breast and detect axillary lymph node metastases from breast cancer.
    Chen J; Wu H; Zhou J; Hu J
    Chin Med J (Engl); 2003 Apr; 116(4):620-4. PubMed ID: 12875735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of recurrent or persistent nasopharyngeal carcinomas after radiotherapy with technetium-99m methoxyisobutylisonitrile single photon emission computed tomography and computed tomography: comparison with 18-fluoro-2-deoxyglucose positron emission tomography.
    Kao CH; Shiau YC; Shen YY; Yen RF
    Cancer; 2002 Apr; 94(7):1981-6. PubMed ID: 11932900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of axillary lymph node involvement in breast cancer patients with positron emission tomography using radiolabeled 2-(fluorine-18)-fluoro-2-deoxy-D-glucose.
    Avril N; Dose J; Jänicke F; Ziegler S; Römer W; Weber W; Herz M; Nathrath W; Graeff H; Schwaiger M
    J Natl Cancer Inst; 1996 Sep; 88(17):1204-9. PubMed ID: 8780629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional breast imaging with Tc 99m Mibi for detection of primary breast lesion and axillary lymph node metastases.
    Usmani S; Khan HA; Javed A; Al Mohannadi S; Al Huda FA; Al Shammary I
    Gulf J Oncolog; 2008 Jul; (4):52-7. PubMed ID: 20084776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative evaluation of 99mTc-MIBI and 99mTc-HMDP scintimammography for the diagnosis of breast cancer and its axillary metastases.
    Nishiyama Y; Yamamoto Y; Ono Y; Irie A; Yamauchi A; Satoh K; Ohkawa M
    Eur J Nucl Med; 2001 Apr; 28(4):522-8. PubMed ID: 11357504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of 18FDG-PET with 131iodine and 99mTc-sestamibi scintigraphy in differentiated thyroid cancer.
    Grünwald F; Menzel C; Bender H; Palmedo H; Willkomm P; Ruhlmann J; Franckson T; Biersack HJ
    Thyroid; 1997 Jun; 7(3):327-35. PubMed ID: 9226199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Scintimammography with technetium-99m methoxyisobutylisonitrile: comparison with mammography and magnetic resonance imaging.
    Palmedo H; Grünwald F; Bender H; Schomburg A; Mallmann P; Krebs D; Biersack HJ
    Eur J Nucl Med; 1996 Aug; 23(8):940-6. PubMed ID: 8753683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. (99)mTc-tetrofosmin SPET in the detection of both primary breast cancer and axillary lymph node metastasis.
    Spanu A; Dettori G; Nuvoli S; Porcu A; Falchi A; Cottu P; Solinas ME; Scanu AM; Chessa F; Madeddu G
    Eur J Nucl Med; 2001 Dec; 28(12):1781-94. PubMed ID: 11734916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.